Live feed09:50:00·35dPRReleasevia Quantisnow+1Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative MarketsByQuantisnow·Wall Street's wire, on your screen.BIOA· BioAge Labs Inc.FATE· Fate Therapeutics Inc.GERN· Geron CorporationLCTX· Lineage Cell Therapeutics Inc.Health Care
